Parkinson’s Disease Market Expands Through Advancements in Neurodegenerative Disease Therapies and
Author : Rohit More | Published On : 17 Jun 2026
According to the latest report published by Data Bridge Market Research, the Parkinson’s Disease Market
Data Bridge Market Research analyses that the global Parkinson’s disease market which was USD 2.80 billion in 2022, would rocket up to USD 5.66 billion by 2030, and is expected to undergo a CAGR of 9.2 % during the forecast period.
This Parkinson’s Disease Market research report is generated with a nice blend of industry insight, talent solutions, practical solutions and use of technology to advance user experience. The key research methodology used in this Parkinson’s Disease Market document by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Nowadays, businesses get highly benefited with the different segments covered in the market research report which provides better market insights to them with which they can drive the business into right direction.
Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-parkinsons-disease-market
Parkinson’s Disease Market Segmentation and Market Companies
Segments
- On the basis of treatment, the global Parkinson's disease market can be segmented into medication and deep brain stimulation. Medication segment is further divided into levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, anticholinergic and others. Deep brain stimulation segment can be classified into unilateral stimulation, bilateral stimulation and others.
- By distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies hold a significant share in the market due to the availability of a wide range of medications and medical devices for Parkinson's disease treatment.
- Based on end-users, the market is segmented into hospitals, specialty clinics and others. Hospitals are the major end-users of Parkinson's disease products due to the high prevalence of patients seeking treatment and the presence of skilled healthcare professionals.
Market Players
- Some of the key market players in the global Parkinson's disease market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Impax Laboratories, Sun Pharmaceutical Industries Ltd., and Merck & Co. Inc. These companies are investing in research and development activities to launch innovative products and expand their presence in the market.
- Other prominent players include UCB S.A., GSK plc, Acadia Pharmaceuticals Inc., Cynapsus Therapeutics, Kyowa Hakko Kirin, and Zydus Cadila. These players are focusing on strategic collaborations and acquisitions to enhance their product portfolios and gain a competitive edge in the market.
The global Parkinson's disease market is witnessing significant growth due to the increasing prevalence of the disease, rising geriatric population, and advancements in healthcare infrastructure. The medication segment dominates the market as it is the primary mode of treatment for managing the symptoms of Parkinson's disease. Deep brain stimulation is gaining traction as an effective alternative for patients who do not respond well to medication therapy. Hospital pharmacies are the leading distribution channel, providing easy access to medications and medical devices for patients. Hospitals remain the primary end-users of Parkinson's disease products, offering comprehensive treatment and care services.
Key market players are focusing on product development, strategic collaborations, and geographic expansion to strengthen their market position and cater to the growing demand for Parkinson's disease treatment. With ongoing research and development initiatives, the market is expected to witness further advancements in treatment options and improved patient outcomes. The competitive landscape of the market is intense, prompting companies to differentiate their offerings and establish a strong market presence.
The global Parkinson's disease market is poised for continued growth driven by factors such as the increasing prevalence of the disease, the aging global population, and ongoing advancements in healthcare infrastructure. As the medication segment remains the cornerstone of Parkinson's disease treatment, with options such as levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications playing a vital role in managing symptoms. Additionally, deep brain stimulation is emerging as a promising alternative for patients who do not respond well to traditional drug therapies, offering a novel approach to symptom management.
In terms of distribution channels, hospital pharmacies are playing a critical role in the market by providing a wide range of medications and medical devices for Parkinson's disease treatment. Their accessibility and ability to offer comprehensive care to patients are key factors driving their significant market share. Moreover, hospitals stand out as the primary end-users of Parkinson's disease products, underscoring the importance of skilled healthcare professionals and specialized care facilities in managing the complex needs of patients with Parkinson's disease.
Key market players such as Teva Pharmaceutical Industries Ltd., Novartis AG, and AbbVie Inc. are spearheading research and development efforts to introduce innovative products and expand their market presence. Collaborations and acquisitions with companies like UCB S.A., GSK plc, and Acadia Pharmaceuticals Inc. are also playing a pivotal role in enhancing product portfolios and gaining a competitive edge in the market. These strategic initiatives reflect the dynamic nature of the Parkinson's disease market, where companies are constantly innovating to meet evolving patient needs and market demands.
Looking ahead, the Parkinson's disease market is poised for further advancements in treatment options and improved patient outcomes as companies continue to invest in research and development. With a competitive landscape characterized by intense competition, market players are striving to differentiate their offerings and establish a strong market presence. By leveraging opportunities for product development, strategic collaborations, and geographical expansion, key players are well-positioned to capitalize on the growing demand for Parkinson's disease treatment and drive continued market growth in the coming years.The global Parkinson's disease market is experiencing substantial growth, driven by various factors such as the increasing prevalence of the disease, the expanding geriatric population, and continuous advancements in healthcare infrastructure. The market is segmented based on treatment into medication and deep brain stimulation. The medication segment, including levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications, remains a crucial aspect of Parkinson's disease management. Deep brain stimulation is emerging as a promising alternative for patients who do not respond well to conventional drug therapies, providing a novel approach to symptom control.
Furthermore, the market segmentation based on distribution channels highlights the significance of hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies play a vital role in the market, offering a wide array of medications and medical devices for Parkinson's disease treatment. They possess a substantial market share due to their accessibility and ability to provide comprehensive care to patients. Also, hospitals are the primary end-users of Parkinson's disease products, emphasizing the importance of skilled healthcare professionals and specialized care facilities in managing the complex needs of patients.
Major market players such as Teva Pharmaceutical Industries Ltd., Novartis AG, and AbbVie Inc. are actively involved in research and development endeavors to introduce innovative products and expand their market presence. Collaborations and acquisitions with companies like UCB S.A., GSK plc, and Acadia Pharmaceuticals Inc. are crucial strategies aimed at enhancing product portfolios and gaining a competitive advantage. This dynamic nature of the market showcases the relentless pursuit of innovation by companies to cater to evolving patient needs and market dynamics.
Looking ahead, the Parkinson's disease market is poised for further advancements in treatment options and improved patient outcomes as companies continue to invest in research and development initiatives. The competitive landscape of the market necessitates differentiation of offerings and establishing a robust market presence. Through opportunities for product development, strategic partnerships, and geographical expansion, key market players are strategically positioned to tap into the growing demand for Parkinson's disease treatment and propel sustained market growth in the foreseeable future.
Frequently Asked Questions About This Report
What are the indicators of a Bubble in the Parkinson’s Disease Market?
What is the impact of e-procurement on Parkinson’s Disease Market efficiency?
What are the top 5 companies by revenue in the Parkinson’s Disease Market?
What are the recent mergers and acquisitions in the Parkinson’s Disease Market?
How is the Parkinson’s Disease Market contributing to the UN Sustainable Development Goals?
Which untapped markets offer the best potential for Parkinson’s Disease Market expansion?
How is Talent Risk (shortage of workers) affecting Parkinson’s Disease Market growth?
What is the Survival Rate for start-ups in the Parkinson’s Disease Market industry?
What are the high-growth pockets in the Parkinson’s Disease Market industry?
How is Artificial Intelligence (AI) being integrated into the Parkinson’s Disease Market?
Who are the major raw material suppliers in the Parkinson’s Disease Market?
Browse More Reports:
Global Smart Collar Tag for Cow Market
Global Parkinson’s Disease Market
Global Industrial Silica Sand Market
Global Tractor Implements Market
Global Corrugated Equipment Market
Global Organic Fast Moving Consumer Goods Market
North America Industrial IoT Market
Global Butane Market
North America Wood Based Panel Market
Global Survival Tools Market
North America Food Grade and Animal Feed Grade Salt Market
Global Computational Fluid Dynamics Market
Global Inertial Navigation System Market
Global Loafers Market
Global Chocolate Inclusions in Bakery Industry Market
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 1006
Email:- [email protected]"
